Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, June 09, 2026 (GLOBE NEWSWIRE) --
BADGER METER, INC. (NYSE: BMI):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders Badger Meter, Inc. (NYSE: BMI). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased or acquired Badger Meter (NYSE: BMI) shares since prior to April 18, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/bmi-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.
WHY? A recently filed federal securities class action alleges that Badger Meter, Inc. (NYSE: BMI), through certain of its officers, repeatedly attributed its strong financial performance to favorable industry trends, robust customer demand, growing adoption of its AMI offerings, strong order activity, backlog conversion, and long-term growth opportunities. According to the complaint, investors were allegedly led to believe that the Company's financial performance reflected sustainable, demand-driven growth and strong underlying business fundamentals.
The complaint further alleges that Badger Meter's reported results were materially impacted by the acceleration or pull-forward of customer orders, which allegedly masked weakening demand trends and depleted future-period revenue opportunities. As a result, investors allegedly received an inaccurate picture of the Company's near-term growth prospects and the sustainability of its financial performance.
It is alleged that the truth emerged through a series of disappointing quarterly announcements during 2025 and 2026, including reports of slowing revenue growth, declining margins, lower utility water sales, weaker municipal customer ordering activity, and reduced earnings performance. Following these announcements, Badger Meter's stock price experienced significant declines.
WHAT CAN YOU DO NOW? If you purchased or acquired Badger Meter (NYSE: BMI) shares prior to April 18, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/bmi-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Badger Meter stock between April 18, 2024 and April 16, 2026, you can participate in the class action.
#BMI #BadgerMeter $BMI
GENEDX HOLDINGS CORP. (NASDAQ: WGS):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased GeneDx Holdings Corp. (NASDAQ: WGS) shares prior to April 16, 2025, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/genedx-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased GeneDX shares between April 16, 2025 and May 4, 2026, you can participate in the class action.
WHY? As alleged in a recently filed securities fraud class action complaint, GeneDx Holdings Corp. (NASDAQ: WGS), through certain of its executives, violated federal securities laws by making false and/or misleading statements pertaining to the impact of the Fabric acquisition on the overall business of the Company. It is alleged that WGS repeatedly made statements that would have caused the average investor to believe that the Fabric acquisition would improve the Company’s financials and create efficiencies between it and the Company’s core business. These statements include such statements such as: “There is room to run in terms of reducing COGS in the future by combining the best of capability between GeneDx and Fabric as we lean into the best possible algorithms to optimize dry lab processes.” These and similar statements when made were false. In truth, it is alleged, Defendants knew of, or recklessly disregarded, significant problems in Fabric’s viability that would negatively impact WGS’s overall business and operations. As a result, the Company’s statements concerning its business, operations, and prospects lacked a reasonable factual basis.
WHAT CAN YOU DO NOW? If you purchased GeneDx Holdings Corp. (NASDAQ: WGS) shares prior to April 16, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. You are encouraged to visit https://grabarlaw.com/the-latest/genedx-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. Alternatively, if you purchased GeneDx shares between April 16, 2025 and May 4, 2026, you can participate in the class action.
$GWS #GWS #GeneDX
GRAIL, INC. (NASDAQ: GRAL):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of GRAIL, Inc. (NASDAQ: GRAL). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased GRAIL, Inc. (NASDAQ: GRAL) shares prior to May 13, 2025, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/grail-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever in a shareholder governance action. Alternatively, if you purchased Grail, Inc. shares between May 13, 2025 and February 19, 2026, you can participate in the class action.
WHY? As alleged in a recently filed securities fraud class action complaint, GRAIL, Inc. (NASDAQ: GRAL), through certain of its officers, violated federal securities laws by making false and/or misleading statements regarding the likelihood that the Company's landmark NHS-Galleri cancer screening trial would achieve its primary endpoint of demonstrating a statistically significant reduction in late-stage (Stage III and IV) cancers. According to the complaint, defendants repeatedly highlighted positive interim metrics, including favorable positive predictive value and other performance indicators, while allegedly creating the impression that the trial was on track to deliver its key clinical objective. The complaint further alleges that defendants failed to disclose material information suggesting that the study's design and follow-up period may have been insufficient to demonstrate the primary endpoint within the anticipated timeframe.
The truth allegedly emerged on February 19, 2026, when GRAIL announced that the NHS-Galleri trial failed to achieve its primary endpoint of a statistically significant reduction in Stage III-IV cancers. Although the Company emphasized certain positive findings, including reductions in Stage IV cancer diagnoses and increased detection of earlier-stage cancers, the complaint alleges that investors learned for the first time that the primary endpoint had not been met and that additional follow-up may be necessary to adequately assess the trial's effectiveness. Following the announcement, GRAIL's stock price fell more than 50% in a single trading day, causing substantial losses to investors.
WHAT CAN YOU DO NOW? If you purchased GRAIL, Inc. (NASDAQ: GRAL) shares prior to May 13, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/grail-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. Alternatively, if you purchased GRAIL shares between May 13, 2025 and February 19, 2026, you can participate in the class action.
#GRAIL #GRAL $GRAL
VERRA MOBILITY CORPORATION (NASDAQ: VRRM):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Verra Mobility Corporation (NASDAQ: VRRM). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Verra Mobility (NASDAQ: VRRM), shares prior to February 24, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/verra-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more. Alternatively, if you purchased Verra Mobility shares between February 24, 2026 and May 26, 2026, you can participate in the class action.
WHY? As alleged in a recently filed federal securities fraud class action complaint, Verra Mobility Corporation (NASDAQ: VRRM), through certain of its executives, violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Verra Mobility’s projected revenue outlook and anticipated growth of its commercial services segment, assurances of contract renewals with major rent-a-car customers, growth in its rental car tolling business and repeatedly affirmed Verra Mobility’s 2026 full year guidance; (ii) Verra Mobility’s optimistic plan for continued growth in its commercial services business was dependent on its relationship with Avis Budget Group, and in particular obtaining a contract extension with Avis Budget Group; and (iii) Verra Mobility minimized concerns that major rent-a-car customers could replace Verra Mobility with in-house solutions or outsourced alternatives, making Verra Mobility’s 2026 full year guidance increasingly unlikely to be met.
On May 26, 2026, Verra Mobility allegedly issued a press release announcing that it had received a termination notice from Avis Budget Group regarding its contract, effective September 2026, and that Verra Mobility’s management lowered its full year 2026 financial outlook as a result. On this news, the price of Verra Mobility stock declined approximately 71%.
WHAT CAN YOU DO NOW? If you purchased Verra Mobility (NASDAQ: VRRM), shares prior to February 24, 2026, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/verra-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Verra Mobility shares between February 24, 2026 and May 26, 2026, you can participate in the class action.
$VRRM #VRRM #Verra #VerraMobility
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
